drug-induced gingival overgrowth and its tentative pharmacotherapy
Clicks: 224
ID: 153854
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
224 views
34 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #19 of 26 articles by views in clinical journal of the american society of nephrology : cjasn
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The characters in gingival fibroblasts derived from a nifedipine-reactive patient (nifedipine responder: NIFr) and those from a nifedipine-nonreactive patient (nifedipine non-responder: NIFn) are summarized, and investigated a possibility of tenidap, (±)-5-chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide, and 18α-glycyrrhetinic acid (18α-GA) as a therapeutics for gingival overgrowth caused by calcium channel blockers. Tenidap discharges intracellular Ca2+ store, resulting in a depletion of intracellular Ca2+ store in cultured human gingival fibroblasts. It also inhibited cell growth, DNA and collagen syntheses, lowered intracellular pH in nicardipine responder cells, and enhanced matrix metalloproteinase-1 formation in NIFr cells. 18α-GA inhibited cell proliferation and G1/S transition induced in NIFr cells. It was also shown that cell cycle control proteins were down-stream targets in the growth-inhibition activity of 18α-GA in NIFr cells. These results suggest that tenidap and 18α-GA might be effective for the prevention of gingival overgrowth caused by calcium channel blockers.
| Reference Key |
matsumoto2010japanesedrug-induced
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Hiroko Matsumoto;Reiri Takeuchi;Makiko Ono;Yoshiaki Akimoto;Naomi Kobayashi;Akira Fujii |
| Journal | clinical journal of the american society of nephrology : cjasn |
| Year | 2010 |
| DOI |
10.1016/j.jdsr.2009.09.001
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.